Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 1 , Pages 135-149 , March 2008

Glycaemic control and perioperative organ protection

  • Joost Berkers (Medical Student)

      Affiliations

    • Equally contributed.
    • ,
  • Jan Gunst, MD (Medical Doctor, Anesthesiologist in training)

      Affiliations

    • Equally contributed.
    • ,
  • Ilse Vanhorebeek, PhD (Post-Doctoral Fellow)
    • ,
  • Greet Van den Berghe, MD, PhD (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +32 16 344021; Fax: +32 16 342290.

References 

  1. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Current Opinion in Clinical Nutrition and Metabolic Care. 1999;21:69–78
  2. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycaemia. Critical Care Clinics. 2001;17:107–124
  3. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. The New England Journal of Medicine. 2001;345:1359–1367
  4. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Critical Care Medicine. 2003;31:359–366
  5. Hill M, McCallum R. Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment. The Journal of Clinical Investigation. 1991;88:811–816
  6. Khani S, Tayek JA. Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clinical Science (London,England:1979). 2001;101:739–747
  7. Watt MJ, Howlett KF, Febbraio MA, et al. Adrenalin increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans. The Journal of Physiology. 2001;534:269–278
  8. Flores EA, Istfan N, Pomposelli JJ, et al. Effect of interleukin-1 and tumor necrosis factor/cachectin on glucose turnover in the rat. Metabolism. 1990;39:738–743
  9. Sakurai Y, Zhang XJ, Wolfe RR. TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. The American Journal of Physiology. 1996;270:E864–E872
  10. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992;130:43–52
  11. Wolfe RR, Durkot MJ, Allsop JR, et al. Glucose metabolism in severely burned patients. Metabolism. 1979;28:1031–1039
  12. Wolfe RR, Herndon DN, Jahoor F, et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. The New England Journal of Medicine. 1987;317:403–408
  13. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. The American Journal of Physiology. 1995;98:75–84
  14. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778
  15. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–2432
  16. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery. 2000;46:335–342
  17. Jeremitsky E, Omert LA, Dunham M, et al. The impact of hyperglycemia on patients with severe brain injury. The Journal of Trauma. 2005;58:47–50
  18. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. The Journal of Trauma. 2003;55:33–38
  19. Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. The Journal of Trauma. 2004;56:1058–1062
  20. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings. Mayo Clinic. 2003;78:1471–1478
  21. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. The Journal of Pediatrics. 2005;146:30–34
  22. Gore DC, Chinkes D, Heggers J, et al. Association of hyperglycemia with increased mortality after severe burn injury. The Journal of Trauma. 2001;51:540–544
  23. Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-year survival, dependency on medical care, and quality-of-life. European Heart Journal. 2006;27:2716–2724
  24. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings. Mayo Clinic. 2004;79:992–1000
  25. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. The New England Journal of Medicine. 2006;354:449–461
  26. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units. benefit versus harm. Diabetes. 2006;55:3151–3159
  27. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Annals of Internal Medicine. 2007;146:233–243
  28. Van den Berghe G. Does tight blood glucose control during cardiac surgery improve patient outcome?. Annals of Internal Medicine. 2007;146:307–308
  29. Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64:1348–1353
  30. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. American Journal of Respiratory and Critical Care Medicine. 2007;175(5):480–489
  31. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocrine Practice. 2004;10(supplementry 2):46–52
  32. Pittas AG, Stegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Archives of Internal Medicine. 2004;164:2005–2011
  33. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. Journal of the American Medical Association. 2005;293:437–446
  34. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. Journal of the American College of Cardiology. 1995;26:57–65
  35. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) study group. BMJ(Clinical Research Ed.). 1997;314:1512–1515
  36. Malmberg K, Ryden L, Hamsten A, et al. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI study group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. European Heart Journal. 1996;17:1337–1344
  37. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. European Heart Journal. 2005;26:650–661
  38. Scott JF, Robinson GM, French JM, et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793–799
  39. Brunkhorst FM, Kuhnt E, Engel C, et al. Intensive insulin therapy in patient with severe sepsis and septic shock is associated with an increased rate of hypoglycemia – results from a randomized multicenter study (VISEP). [abstract] Infection. 2005;33(supplementry 1):19
  40. http://webanae.med.unijena.de/WebObjects/DSGPortal.woa/WebServerResources/sepnet/visep.html
  41. National Institutes of Health. Glucontrol study: comparing the effects of two glucose control regimens by insulin in intensive care unit patients. Available from http://www.clinicaltrials.gov/ct/show/NCT00107601 and http://www.glucontrol.org/
  42. Clinicaltrials.gov. Normoglycemia in intensive care evaluation and survival using glucose algorithm regulation (NICE-SUGAR study) [accessed May 13, 2007], at http://www.clinicltrials.gov/ct/show/NCT00220987)
  43. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelies for management of severe sepsis and septic shock. Critical Care Medicine. 2004;32:858–873
  44. Boord JB, Graber AL, Christman JW, et al. Practical management of diabetes in critically ill patients. American Journal of Respiratory and Critical Care Medicine. 2001;164:1763–1767
  45. Vriesendorp TM, De Vries JH, van Santen S, et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Critical Care Medicine. 2006;34:2714–2718
  46. Mackenzie I, Ingle S, Zaidi S, et al. Hypoglycemia? So what!. Intensive Care Medicine. 2006;32:620–621
  47. Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients. Journal of the American Medical Association. 2003;290:2041–2047
  48. Jolliet P, Pichard C, Biolog G, et al. Enteral nutrition in intensive care patients: a practical approach. Intensive Care Medicine. 1998;24:848–859
  49. Kanji S, Buffie J, Hutton B, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Critical Care Medicine. 2005;33:2778–2785
  50. Vlasselaers D, Schaupp L, van den Heuvel I, et al. Monitoring blood glucose with microdialysis of interstitial fluid in critically ill children. Clinical Chemistry. 2007;53:1–2
  51. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. The Journal of Clinical Investigation. 2004;114:1187–1195
  52. Vanhorebeek I, Van den Berghe G. The diabetes of injury: novel insights. Endocrinology and Metabolism Clinics of North America. 2006;35:859–872
  53. Ellger B, Debaveye Y, Vanhorebeek I, et al. Survival benefits of intensive insulin therapy in critical illness. Diabetes. 2006;55:1096–1105
  54. Klip A, Tsakiridis T, Marette A, Ortiz PA. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. The FASEB Journal. 1994;8:43–53
  55. Pekala P, Marlow M, Heuvelman D, Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor alfa, but not by insulin. The Journal of Biological Chemistry. 1990;265:18051–18054
  56. Shikhman AR, Brinson DC, Valbracht J, Lotz MK. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. Journal of Immunology. 2001;167:7001–7008
  57. Quinn LA, McCumbee WD. Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells. Journal of Cellular Physiology. 1998;177:94–102
  58. Clerici C, Matthay MA. Hypoxia regulates gene expression of alveolar epithelial transport proteins. Journal of Applied Physiology. 2000;88:1890–1896
  59. Sanchez-Alvarez R, Tabernero A, Medina JM. Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: relationship with gap junctional communication. Journal of Neurochemistry. 2004;89:703–714
  60. Tirone TA, Brunicardi C. Overview of glucose regulation. World Journal of Surgery. 2001;25:461–467
  61. Vanhorebeek I, De Vos R, Mesotten D, et al. Strict blood glucose control with insulin in critically ill patients protects hepatocytic mitochondrial ultrastructure and function. Lancet. 2005;365:53–59
  62. Rassias AJ, Marrin CA, Arruda J, et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia and Analgesia. 1999;88:1011–1016
  63. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes. 1989;38:1031–1035
  64. Perner A, Nielsen SE, Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Medicine. 2003;29:642–645
  65. Rayfield EJ, Ault MJ, Keusch GT, et al. Infection and diabetes: the case for glucose control. The American Journal of Medicine. 1982;72:439–450
  66. Pozzili P, Leslie RD. Infections and diabetes: mechanisms and prospects for prevention. Diabetic medicine: A Journal of the British Diabetic Association. 1994;11:935–941
  67. Weekers F, Van Herck E, Coopmans W, et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a bi-phasic neuroendocrine stress response. Endocrinology. 2002;143:764–774
  68. Weekers F, Giuletti A, Michalaki M, et al. Endocrine and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003;144:5329–5338
  69. Lanza-Jacoby S, Wong SH, Tabares A, et al. Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. Biochimica et Biophysica Acta. 1992;1124:233–240
  70. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. The Journal of Infectious Diseases. 2000;181:S462–S472
  71. Carpentier YA, Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Current Opinion in Clinical Nutrition and Metabolic Care. 2002;5:153–158
  72. Mesotten D, Swinnen JV, Vanderhoydonc F, et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. The Journal of Clinical Endocrinology and Metabolism. 2004;89:219–226
  73. Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Annals of Surgery. 2004;239:553–560
  74. Gore DC, Wolf SE, Sanford AP, et al. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. American Journal of Physiology. Endocrinology and Metabolism. 2004;286:E529–E534
  75. Agus MSD, Javid PJ, Ryan DP, Jaksic T. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. Journal of Pediatric Surgery. 2004;39:839–844
  76. Zhang XJ, Chinkes DL, Irtun O, Wolfe RR. Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids. American Journal of Physiology. Endocrinology and metabolism. 2002;282:E1308–E1315
  77. Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. The Journal of Clinical Investigation. 2005;155:2277–2286
  78. Siroen MPC, van Leeuwen PAM, Nijveldt RJ, et al. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?. Critical Care Medicine. 2005;33:504–510
  79. Nijveldt RJ, Teerlink T, van Leeuwen PA. The asymmetric dimethylarginine (ADMA)-multiple organ failure hypothesis. Clinical Nutrition. 2003;22:99–104
  80. Das UN. Insulin: an endogenous cardioprotector. Current Opinion in Critical Care. 2003;9:375–383
  81. Gao F, Gao E, Yue T, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the role of PI3-kinase, Akt and eNOS phosphorylation. Circulation. 2002;105:1497–1502
  82. Jonassen A, Sack M, Mjos O, Yellon D. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signalling. Circulation Research. 2001;89:1191–1198
  83. Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients, as indicated by circulating mannose-binding lectin and C-reactive protein levels. The Journal of Clinical Endocrinology and Metabolism. 2003;88:1082–1088
  84. Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology. 2004;145:4084–4093
  85. Klein D, Schubert T, Horch RE, et al. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Annals of Surgery. 2004;240:340–349
  86. Brix-Christensen V, Andersen SK, Andersen R, et al. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology. 2004;100:861–870
  87. Vanhorebeek I, Peeters RP, Vander Perre S, et al. Cortisol response to critical illness: effect of intensive insulin therapy. The Journal of Clinical Endocrinology and Metabolism. 2006;91:3803–3813
  88. Inzucchi SE. Management of hyperglycemia in the hospital setting. The New England Journal of Medicine. 2006;355:1903–1911

PII: S1521-6896(07)00077-8

doi: 10.1016/j.bpa.2007.08.002

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 1 , Pages 135-149 , March 2008

Article Tools